| Title |
Publication Date |
Price |
Relevance |
China Pharmaceutical Industry Report
2006-2007
|
July 2007 |
£190 |
100 % |
Chinese Pharmaceutical Industry - Access China
|
January 2006 |
£225 |
98 % |
China Pharmaceutical Industry: Analysis and Market Trends
|
January 2009 |
£255 |
97 % |
China Pharmaceutical Industry Report (Merger & Reorganization), 2006
|
August 2006 |
£1465 |
96 % |
China Pharmaceutical Industry Report (Merger and Reorganization), 2006-2007
|
January 2007 |
£1080 |
95 % |
Pharmaceutical Raw Materials Manufacturing in China
IBISWorld Industry Report
|
October 2008 |
£260 |
50 % |
China Pharmaceutical Chain Industry Report, 2006
|
August 2006 |
£955 |
49 % |
Pharma China Journal Edition
|
December 2008 |
£1050 |
43 % |
Understanding China's Chemical Industry
Worldwide Companies Take Advantage of China's Chemical Industry
|
January 2009 |
£315 |
43 % |
China Product Registration and Regulatory Issues Webcast CD
|
March 2007 |
£255 |
40.5 % |
Pharmaceutical and Medicine Manufacturing in China
IBISWorld Industry Report
|
August 2009 |
£400 |
40.5 % |
Pharma China Gold Package
|
December 2008 |
£1750 |
39.5 % |
China Pharmaceutical & Biotechnology Monthly
(Single user, one year subscription)
|
September 2008 |
£1275 |
39 % |
Business and Marketing Strategy for China's Pharmaceutical Market Webcast CD
|
October 2007 |
£255 |
38.5 % |
Pharmaceutical Directory of China
2009
|
April 2009 |
£160 |
37.5 % |
China Biopharmaceutical Industry Report, 2006-2007
|
March 2007 |
£190 |
35 % |
Analysis Report on China Antibiotic Industry
|
June 2007 |
£125 |
34 % |
China Bio-services & Database Package
|
May 2006 |
£1275 |
33 % |
Global Pharmaceuticals Industry 2006 - Power Point Presentation (Editable)
|
July 2007 |
£400 |
32.5 % |
China Pharma Outsourcing Market By 2015
|
January 2009 |
£1110 |
32 % |
Snapshots China Pharmaceuticals 2005
|
October 2005 |
£150 |
32 % |
China Anesthesia Apparatus Market Report
2008
|
April 2008 |
£645 |
31.5 % |
Business Opportunities in China
The impact of the WTO - 2nd Edition
|
March 2006 |
£400 |
31.15 % |
Snapshots China OTC Pharmaceuticals 2009
|
May 2009 |
£300 |
30 % |
The Chinese Pharmaceutical Directory 2008
How to keep up-to-date with China's Pharmaceutical businesses and discover hundreds of new business leads
|
November 2007 |
£215 |
29 % |
Snapshots China Pharmaceuticals 2007
|
March 2007 |
£150 |
29 % |
Snapshots China Pharmaceuticals 2009
|
May 2009 |
£300 |
28 % |
Pharmaceutical Product Lifecycle Management Forecast in APAC 2006-2012 (Databook)
|
July 2007 |
£695 |
28 % |
CHINA: Major report covers impact of health reforms on China's Pharmaceutical Market
Impact of China's Health Reforms
|
October 2009 |
£125 |
27 % |
Chemicals in China
|
December 2008 |
£132 |
26.5 % |
Pharmaceutical Markets in Brazil, Russia, India and China (Bric Nations)
|
July 2008 |
£1125 |
26.5 % |
Top 100 Best Pharma Outsourcing Service Providers in China and India
|
July 2009 |
£600 |
26 % |
China Medical Devices Market Report
2007
|
July 2007 |
£235 |
24.85 % |
China Pharmaceuticals and Healthcare Report Q3 2008
|
September 2008 |
£425 |
24.5 % |
Lotus Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
|
June 2009 |
£80 |
24.5 % |
China Pharmaceuticals and Healthcare Report Q4 2008
|
November 2008 |
£250 |
24.15 % |
China Pharmaceutical Market Report 2009
|
January 2009 |
£340 |
24.15 % |
200 China-based Best CROs and CMOs
|
March 2009 |
£955 |
24 % |
Drug Discovery in India and China
Gaining Momentum with Increasing Pressure on Cost Cutting
|
February 2010 |
£2230 |
24 % |
China Medicated Health Product Industry Report
2007
|
June 2007 |
£285 |
23.45 % |
China Sky One Medical, Inc. - Financial and Strategic Analysis Review
|
June 2009 |
£80 |
23 % |
Biosimilars
Problems, Prospects and Projections
|
April 2009 |
£215 |
23 % |
World Market for Prescription Generic Drugs
6th Edition
|
April 2008 |
£2545 |
23 % |
Latest Chinese Regulations for Imported Drug Registration
China Pharmaceutical Guidebook
|
June 2008 |
£885 |
22.5 % |
Chemicals in Australia
|
December 2008 |
£132 |
22 % |
Chemicals in Asia-Pacific
|
December 2008 |
£132 |
22 % |
Chemicals in India
|
December 2008 |
£132 |
22 % |
Chemicals in Taiwan
|
December 2008 |
£132 |
22 % |
Chemicals in South Korea
|
December 2008 |
£132 |
22 % |
Chemicals in Singapore
|
December 2008 |
£132 |
22 % |
Health Care Equipment & Supplies in China
|
July 2008 |
£180 |
21.7 % |
Consolidation in the Generic Pharmaceutical Industry
An evolving landscape
|
October 2007 |
£1250 |
21.5 % |
Chinese Markets for Pharmaceutical Packaging
|
June 2009 |
£2440 |
21.35 % |
Generics in China
|
August 2007 |
£125 |
20.65 % |
The Pharmaceutical Market
Spain
|
May 2008 |
£595 |
20.5 % |
Taiwan Pharmaceuticals and Healthcare Report Q3 2007
|
February 2009 |
£250 |
20.5 % |
China Pharmaceutical Regulatory Report 2009
|
January 2009 |
£1020 |
20.3 % |
OTC Pharmaceuticals in China
|
February 2009 |
£132 |
20.3 % |
Chemicals in Europe
|
December 2008 |
£132 |
20 % |
Global Chemicals
|
December 2008 |
£132 |
20 % |
Drug Targets for Breast Cancer
|
January 2006 |
£1095 |
20 % |
Advances in Biopharmaceutical Technology in China
|
September 2006 |
£3410 |
19.95 % |
Chinese Markets for Antibiotics
|
April 2009 |
£2755 |
19.6 % |
Pharmaceuticals in Japan
|
March 2009 |
£132 |
19.6 % |
Understanding the Global Pharmaceutical Market
|
November 2008 |
£315 |
19.6 % |
Emerging Markets Series: The Pharmaceutical Market of South Korea
|
October 2008 |
£4000 |
19.5 % |
The Asian Cardiovascular Market Outlook to 2014
Regional and therapeutic analysis, pipeline impact and growth opportunities
|
March 2009 |
£2025 |
19.5 % |
China Vaccine Market Report 2007-2009
|
July 2008 |
£860 |
19.25 % |
3SBio Inc. - Financial and Strategic Analysis Review
|
June 2009 |
£80 |
19 % |
China Medical Sales Channel Report, 2006-2007
|
March 2007 |
£575 |
18.9 % |
Chinese Pharmaceutical Industry
Strategies, Trends and Opportunities
|
August 2005 |
£3330 |
18.2 % |
Guide to Pharmaceutical Outsourcing in China
|
February 2008 |
£625 |
18.2 % |
Managing Sales Training to Accelerate Speed to Productivity
|
December 2004 |
£1530 |
18 % |
The Outlook for Pharmaceuticals in North East Asia
to 2014
|
June 2009 |
£1995 |
18 % |
Therapeutic Monoclonal Antibodies Report 2008-2023
|
July 2008 |
£1499 |
18 % |
Pakistan Pharmaceuticals and Healthcare Report Q1 2009
|
January 2009 |
£250 |
18 % |
AMDL, Inc. - Financial and Strategic Analysis Review
|
June 2009 |
£80 |
18 % |
China Blood Products Industry Report
2009
|
October 2009 |
£765 |
17.85 % |
Optimizing PLM Technology for the Pharmaceutical Industry (Technology Focus)
|
July 2007 |
£1000 |
17.85 % |
Alliance Boots GmbH - Strategic Analysis Review
|
July 2009 |
£80 |
17.5 % |
Global Vaccine Market Outlook (2007-2010)
|
June 2007 |
£1020 |
17.5 % |
Global Vaccines Market 2008-2023, The
|
August 2008 |
£1499 |
17 % |
Offshoring Clinical Trials
(The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel)
|
November 2007 |
£2230 |
17 % |
Drugs: From Discovery to Approval
2nd Edition
|
January 2004 |
£43.5 |
17 % |
Insulin Delivery Systems Market Analysis (2008-2012)
|
August 2009 |
£890 |
16.5 % |
The China Pharmaceutical Market: A Strategic Opportunity Analysis
|
January 2007 |
£840 |
16.45 % |
Indian Bulk Drug Industry Insight 2007
|
May 2007 |
£400 |
16.1 % |
Evaluation of Current Service Capabilities of Chinese Pharmaceutical Outsourcing Service Industry
|
May 2008 |
£560 |
16.1 % |
World Vaccines Market 2008-2013
Future Forecast, Critical Trends and Developments
|
April 2009 |
£325 |
16 % |
Asia Generic Pharmaceuticals Forecast Report; The
|
July 2006 |
£510 |
15.75 % |
Streamlining Information in the Pharmaceutical Industry with PLM (Review Report)
|
August 2007 |
£1795 |
15.75 % |
Asia Pacific Pharma Sector Analysis
|
November 2009 |
£765 |
15.75 % |
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
A Study of Biotherapeutic Developers and Contract Manufacturing Organizations, 2007
|
April 2008 |
£1010 |
15.5 % |
Mitsubishi Pharma:
Pipeline, Products, Performance, Potential
|
October 2007 |
£595 |
15.5 % |
Global Pharmaceuticals, Biotechnology & Life Sciences
|
May 2008 |
£230 |
15.5 % |
China's Attraction and Strategies to Work with It
Analysis of Best Strategies for Western Pharmaceutical and Biotech Companies to Partner with Chinese Pharmaceutical Companies
|
July 2008 |
£955 |
15.4 % |
China's Attraction and Strategies to Work with It
Analysis of Best Strategies for Western Pharmaceutical and Biotech Companies to Partner with Chinese Pharmaceutical Comp
|
July 2008 |
£1020 |
15.4 % |
Comparison of Pharma Outsourcing between China and India
|
July 2009 |
£955 |
15.4 % |
Drug Development Opportunities In China
Regulation, Key Players And Initiatives For Domestic And International Markets
|
September 2007 |
£1495 |
15.05 % |
World Pharmaceutical Market (2007)
|
November 2006 |
£475 |
15.05 % |
Chinese Markets for Biotechnology
|
August 2006 |
£2545 |
15.05 % |
World Diabetes Market Analysis 2009-2023
|
February 2009 |
£1499 |
15 % |
Latin American Developing Markets for Pharmaceuticals, 2006-2011
|
November 2006 |
£1999 |
14.7 % |
The Outlook for Pharmaceuticals in Latin America
|
March 2007 |
£1995 |
14.5 % |
Conducting Clinical Trials in Emerging Markets
|
January 2007 |
£2395 |
14.5 % |
Global Pharmaceuticals - Yearly Update 2006
|
July 2007 |
£600 |
14.35 % |
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide
|
September 2009 |
£995 |
14.35 % |
Executive Summary of the BioChips & BioMEMS (Biomedical Microelectromechanical Systems) Markets
2006-2011 Analysis & Forecasts
|
May 2006 |
£695 |
14 % |
The Outlook for Pharmaceuticals in Central Asia
|
March 2007 |
£1995 |
14 % |
The Pharmaceutical Market
Taiwan
|
May 2008 |
£595 |
13.65 % |
Dental Products in China
Industry forecasts for 2012 & 2017
|
January 2009 |
£3245 |
13.65 % |
The Pharmaceutical Market
Taiwan
|
May 2008 |
£595 |
13.65 % |
The Future of the Pharmaceutical Packaging Industry
Emerging Economies Poised to Capitalize on Increasing Demand
|
December 2009 |
£2230 |
13.65 % |
Anti-Obesity Treatments
Analysis & Forecasts 2009-2024
|
February 2009 |
£1499 |
13.5 % |
Top 10 Generic Pharmaceutical Companies, The
Positioning, Performance and SWOT Analyses
|
July 2008 |
£1995 |
13.5 % |
Clinical Nutrition Products
World Markets, 3rd Edition
|
February 2009 |
£2415 |
13.5 % |
Pharmaceuticals in China
|
February 2006 |
£3055 |
13.3 % |
How Drugs Are Developed
3rd Edition
|
January 2007 |
£1095 |
13 % |
Emerging Pharmaceutical Markets Globally
|
April 2008 |
£955 |
12.95 % |
Central and Eastern European (CEE) Developing Markets for Pharmaceuticals, 2006-2011
|
November 2006 |
£1999 |
12.95 % |
Contract Manufacturing Strategies
Market developments, technology transfer and key success factors
|
May 2008 |
£2325 |
12.6 % |
The World OTC Pharmaceutical Market Analysis & Forecasts, 2008-2023
|
June 2008 |
£1499 |
12.6 % |
Achieving success in the Developing Asian Pharmaceutical Sector 2007-2011
|
November 2006 |
£1999 |
12.6 % |
OTC Pharmaceuticals in Taiwan
|
February 2009 |
£132 |
12.6 % |
China’s Guidebook for Pharmaceutical Patent Protection
|
June 2008 |
£950 |
12.6 % |
Monoclonal Antibody Therapeutics 2009-2024
|
August 2009 |
£1499 |
12.5 % |
Astellas Pharma Inc. - Financial and Strategic Analysis Review
|
July 2009 |
£80 |
12.5 % |
Disposable Devices - An Outperforming Medical Device Segment
|
July 2009 |
£440 |
12.25 % |
The Outlook for Pharmaceuticals in South East Asia
|
March 2007 |
£1995 |
12 % |
Chinese Markets for Health Care
|
November 2006 |
£2545 |
11.9 % |
Global Biotechnology -Yearly Update 2006
|
July 2007 |
£600 |
11.9 % |
The Future of Contract Manufacturing
Market Forecasts to 2015
|
December 2009 |
£2230 |
11.9 % |
BioChips & BioMEMS (Bio Microelectromechanical Systems) World Markets, Applications & Opportunities
2006-2011 Analysis & Forecasts
|
May 2006 |
£1145 |
11.5 % |
China Pharma Outsourcing Annual Review
2009
|
November 2009 |
£880 |
11.2 % |
Innovative Drug R&D in China
|
October 2009 |
£1845 |
11.2 % |
Contract Research and Manufacturing Services
India (CRAMS)
|
March 2008 |
£600 |
11.2 % |
Global Bulk Drugs Industry Report
|
August 2006 |
£550 |
10.85 % |
Malaysia: Country Scan
Country Scan
|
August 2006 |
£550 |
10.85 % |
Asia Pacific Anesthesia and Respiratory Devices Investment Opportunities, Analysis and Forecasts to 2015
|
June 2009 |
£1590 |
10.85 % |
Clinical Trials Market 2006, The
|
February 2006 |
£1499 |
10.85 % |
Generics in the Animal Health Industry
|
January 2006 |
£795 |
10.5 % |
World Pharmaceutical Packaging
Forecasts For 2011 & 2016 For 18 Countries
|
July 2007 |
£3690 |
10.5 % |
Key Players in Pharmaceutical Contract Manufacturing
Market developments, outsourcing hotspots and growth strategies
|
March 2009 |
£2025 |
10.15 % |
Outsourcing Clinical Trials
A Global Analytical Guide and Comparative Analysis of International Destinations, with Location Attractiveness Index
|
May 2007 |
£1910 |
10.15 % |
Negotiating The Emerging Biosimilars Landscape
Key Developments in The Regulatory Environment
|
February 2009 |
£2025 |
9.8 % |
Global Protein Therapeutics Market Analysis
|
August 2009 |
£1145 |
9.8 % |
Winning R&D Productivity Strategies
Exploiting innovation, licensing and outsourcing opportunities
|
October 2006 |
£1495 |
9.8 % |
The Top 60 Blood Glucose Monitoring Device Companies Worldwide
|
August 2009 |
£365 |
9.5 % |
Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution
Issues, initiatives and insights for supply chain integrity
|
September 2009 |
£3835 |
9.45 % |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£1020 |
9.45 % |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£505 |
9.45 % |
The Indian Pharmaceutical Market to 2011
Competitive dynamics and major players
|
July 2007 |
£1495 |
9.45 % |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£505 |
9.45 % |
World Contract Research and Manufacturing Market, 2006-2011, The
Trends in Outsourcing
|
August 2006 |
£1499 |
9.45 % |
Global. Generics
|
April 2009 |
£800 |
9.45 % |
Contract Pharma 2008-2023
|
August 2008 |
£1499 |
9.1 % |
Global Generics Industry Report
|
September 2006 |
£550 |
9.1 % |
The Top 10 Contract Research Organizations
Positioning, performance and SWOT analyses
|
March 2009 |
£2025 |
8.75 % |
Pharmaceutical Pricing and Reimbursement
Reference Pricing and Economic Evaluations Will Dominate Future Pricing and Reimbursement Strategies
|
February 2010 |
£2230 |
8.75 % |
World Enzymes
Study # 2229
|
September 2007 |
£3435 |
8.75 % |
Stem Cell Research
Market Trends, Investment Trends and Pipeline Analysis
|
February 2010 |
£2230 |
8.75 % |
Global Biotechnology Industry 2006
|
June 2006 |
£550 |
8.4 % |
Who is Who in Clinical Diagnostics in China
(Manufacturers and Distributors Profiles, Market, Industry Overview )
|
May 2009 |
£2545 |
8.4 % |
Outsourcing in Drug Discovery, 3rd Edition
|
May 2008 |
£1905 |
8.4 % |
Biochips
A Global Update of Market Trends & Opportunities
|
November 2009 |
£1905 |
8.05 % |
Pharmaceutical Pricing And Reimbursement
Strategies For Market Access Across The Us, Europe, Japan And Other Key Geographies
|
November 2007 |
£1495 |
8.05 % |
World Generics Market, 2008-2013
|
November 2008 |
£1499 |
8.05 % |
Global Clinical Trial Business Report & Analysis 2008-2018
|
July 2008 |
£1499 |
8.05 % |
The Indian Pharmaceutical Market Analysis and Forecasts 2008-2023
|
May 2008 |
£1499 |
7.7 % |
Manufacturing in the Global Pharmaceuticals Industry
Key drivers, company strategies and regulations (3rd Edition)
|
September 2008 |
£899 |
7.7 % |
The Future of Contract Research Outsourcing
Market Forecasts to 2015, Geographical Landscape and Competitive Benchmarking
|
December 2009 |
£2230 |
7.7 % |
World Nutraceuticals to 2010
|
July 2006 |
£3500 |
7.7 % |
Pain Management
Global Trends
|
November 2009 |
£1905 |
7.35 % |
Clinical Trials: World Market 2009-2024
|
July 2009 |
£1499 |
7.35 % |
Key Trends in Offshoring Pharmaceutical R&D
Company strategies, emerging markets and impact on ROI
|
March 2009 |
£2025 |
7.35 % |
Drug Registration in China
A comprehensive overview of procedures
|
September 2008 |
£495 |
7.35 % |
Pricing & Reimbursement in Asia-Pacific
|
January 2006 |
£1095 |
7 % |
The Pharmaceutical Industry 2008
Current and Future Trends and Strategic Issues Shaping Pharma
|
March 2008 |
£3010 |
6.65 % |
Hospira, Inc. Medical Equipment Company Report
Medical Device Company Analysis Covering key Information Relating to Company Market Share by Sector and Country, Financial, SWOT and Value Chain Analysis
|
April 2008 |
£635 |
6.65 % |
Ophthalmic Pharmaceuticals, Market Analysis, Forecasts and Dynamics
2009-2023
|
January 2009 |
£1499 |
6.65 % |
Osteoporosis & Bone Metabolism Disorders Market
2008-2023
|
August 2008 |
£1499 |
6.3 % |
Pharmaceutical Contract Manufacturing and Research
|
May 2005 |
£3085 |
6.3 % |
World Generics Market 2006-2011; The
|
May 2006 |
£1499 |
5.95 % |
Membrane Microfiltration Market; The
|
March 2006 |
£3085 |
5.95 % |
Market for Organ and Tissue Transplantation and Alternatives; The
|
October 2005 |
£3085 |
5.95 % |
Syringes (Disposable and Reusable)
Global Market Opportunities
|
November 2009 |
£1905 |
5.6 % |
Osteoporosis Therapeutics
A Global Market Perspective
|
November 2009 |
£1905 |
5.6 % |
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
|
April 2007 |
£1499 |
5.25 % |
Future Growth Opportunities in Generics
The impact of consolidation on market and competitive dynamics
|
November 2006 |
£1495 |
5.25 % |
Clinical Trials Business; The
|
August 2006 |
£3085 |
5.25 % |
Patient Monitoring Markets
|
October 2009 |
£2165 |
5.25 % |
GenericHandbook - Third Edition (2009)
A Guide to the Generic Drug Industry in the US
|
April 2009 |
£475 |
4.55 % |
Commercial Insight: Antihypertensives
New challenges for a maturing market
|
September 2006 |
£8000 |
4.55 % |
In Vitro Diagnostics Market Report & Analysis 2008-2023
|
June 2008 |
£1499 |
4.55 % |
Stakeholder Opinions: Tuberculosis - Development pipeline shows signs of life
Healthcare
|
March 2009 |
£2000 |
4.55 % |
Nanomedicine
|
July 2009 |
£2515 |
4.2 % |
Incremental Improvements And Paradigm Shifts In Strategy Are Both Necessary To Boost Productivity
R&D Strategies
|
August 2007 |
£7600 |
4.2 % |
Commercial Insight: Antidyslipidemics
Branded statins beware, generics are amongst you
|
July 2006 |
£8440 |
4.2 % |
Emotional and Behavioral Disorders in Children and Adolescents
|
September 2005 |
£3085 |
3.85 % |
Global Cardiovascular Drugs Market 2009-2024
|
June 2009 |
£1499 |
3.85 % |
Small Molecule Kinase Inhibitors
|
July 2009 |
£2515 |
3.85 % |
Commercial Insight: Cardiovascular market overview
Raft of patent expires threaten blockbusters
|
October 2007 |
£7600 |
3.85 % |
Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries
|
July 2007 |
£7600 |
3.5 % |
Drug Discovery Technologies
A Global Update of Market Trends & Opportunities
|
November 2009 |
£1905 |
3.5 % |
Autoimmune Disease Therapeutics
|
July 2009 |
£2515 |
3.5 % |
Blood Banking and Blood Products
Global Market Perspective
|
November 2009 |
£1905 |
3.5 % |
Commercial Insight: Antidyslipidemics
The competitive cost-conscious antidyslipidemics market presents challenges
|
July 2007 |
£7600 |
3.15 % |
New Dynamics and Challenges in The Generics Market 2007
|
January 2007 |
£1870 |
3.15 % |
World Generic Market Report 2009
|
January 2009 |
£595 |
3.15 % |
PAREXEL's Bio/Pharma R&D Statistical Sourcebook
2009 / 2010
|
June 2009 |
£270 |
3.15 % |
Membrane Bioreactors
|
July 2009 |
£2515 |
3.15 % |
Parexel's Pharmaceutical R&D Statistical Sourcebook 2007/2008
|
May 2007 |
£270 |
3.15 % |
Commercial Insight: Asthma & COPD
|
June 2009 |
£15200 |
3.15 % |
Protein Therapeutics Market; The
The Science and Business of a Growing Sector
|
June 2006 |
£2480 |
2.8 % |
All Change in the Advanced Wound Care Market 2009
|
May 2009 |
£795 |
2.8 % |
Lung Cancer Therapeutics
|
July 2009 |
£2515 |
2.45 % |
Terumo Medical Device Company Intelligence Report
|
February 2006 |
£295 |
2.45 % |
Nanobiotechnology
Applications, Markets and Companies
|
February 2010 |
£2865 |
2.1 % |
